Abstract:Real-world data on acute coronary syndrome (ACS) patients who received intra-aortic balloon pump (IABP) support are limited. The objective of this study was to evaluate the characteristics of ACS patients who received IABP support from a real-world ACS registry. Patients with ACS (N = 121) who received IABP support were enrolled. Characteristics of survivors and nonsurvivors were compared at 30 days. Mortality rate of patients with ACS who received IABP was 47%. The survivors (N = 64) had less often cardiogenic shock (p < 0.001), more often IABP usage as back-up for a revascularization procedure (p = 0.002), less often resuscitation (p = 0.043), and less mechanical ventilator support (p < 0.001) than nonsurvivors. The nonsurvivors had a significantly higher leukocyte count (p = 0.033), a higher serum creatinine level (p < 0.001), a higher blood sugar on admission (p = 0.001), higher creatine kinase MB levels (p = 0.002), and a higher serum uric acid level (p < 0.001), but significantly lower left and right ventricular function (p = 0.014 and p = 0.003, respectively) than survivors. At 30 days, non-ST elevation (STE)-ACS patients had lower mortality rate than ST segment elevation myocardial infarction patients (log-rank test, p < 0.001), and non-STE-ACS patients who had not suffered from cardiogenic shock showed the lowest mortality rate (log-rank test, p < 0.001). By multivariate analysis, a heart rate ≥ 100 beats per minute before IABP insertion was the strongest predictor of 30-day mortality (hazard ratio = 5.69; 95% confidence interval, 1.49 to 21.78; p = 0.011). In ACS patients presenting with either cardiogenic shock, resuscitated, or patients who needed mechanical ventilation suffered from high mortality, despite the use of IABP. IABP appears to be safe and tended to be favorable in noncardiogenic shock ACS patients, particularly non-STE-ACS. A heart rate of ≥ 100 beats per minute prior to IABP insertion was the strongest predictor of 30-day mortality.

INTRA-AORTIC BALLOON PUMP ON IN-HOSPITAL OUTCOMES OF CARDIOGENIC SHOCK: FINDINGS FROM THE HOSPITAL QUALITY MONITORING SYSTEM (HQMS) REGISTRY

Intra‐aortic Balloon Pump on In‐hospital Outcomes of Cardiogenic Shock: Findings from a Nationwide Registry, China

Effects of intra-aortic balloon pump on in-hospital outcomes and 1-year mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Application of intraaortic balloon counterpulsation during primary percutaneous coronary intervention in patients with cardiogenic shock complicating with acute myocardial infarction

Application of intra-aortic balloon pump in acute myocardial infarction complicared with cardiogenic shock undergoing percutaneous coronary intervention

Use of intraaortic balloon pump in cardiogenic shock patients

A multivariate and retrospective analysis of the impact of intra-aortic balloon counterpulsation in Open-Heart surgery

The Preference, Effect, and Prognosis of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock Patients: A Retrospective Cohort Study

The Outcomes of Intra-Aortic Balloon Pump Usage in Patients with Acute Myocardial Infarction: a Comprehensive Meta-Analysis of 33 Clinical Trials and 18,889 Patients.

The Use of Intra-aortic Balloon Pump in a Real-World Setting: A Comparison between Survivors and Nonsurvivors from Acute Coronary Syndrome Treated with IABP. The Jakarta Acute Coronary Syndrome Registry

GW27-e0365 A Meta-analysis of the Efficacy and Safety of Adjunctive Intra-Aortic Balloon Pump in Patients with Acute Myocardial Infarction

Application of intra-aortic balloon pump in acute myocardial infarction

Application of Intra-Aortic Balloon Counterpulsation in Patients with Acute Myocardial Infarction

Intra-aortic balloon pump after VA-ECMO reduces mortality in patients with cardiogenic shock: an analysis of the Chinese extracorporeal life support registry

Haemodynamic effects of intra‐aortic balloon pumps stratified by baseline pulmonary artery pulsatility index

GW26-e0741 Fractional Flow Reserve Guided Percutaneous Coronary Intervention improves clinical outcome with reduced cost in Chinese real world practice

Research progress of intra-aortic balloon counterpulsation in the treatment of acute myocardial infarction with cardiogenic shock: A review

Therapeutic Efficacy of Intra-Aortic Balloon Pump Support in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Percutaneous Coronary Intervention

Clinical evaluation of intra aortic balloon couterpulsation in percutaneous coronary interention for patients with acute myocardial infarction combined with cardiogenic shock

Clinical analysis of 33 patients with acute myocardial infarction implanted with intra-aortic balloon counterpulsation

GW26-e0189 Intra-aortic Balloon Pump is Irrelevant to the Short and Long Term Mortality Rate of Patients with Acute Myocardial Infarction